IMA vs TM · rev $9.2M vs P/E 9.7, rev $234.60B
ImageneBio, Inc. (IMA) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
IMA currently screens at market cap $64.7M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the IMA and TM stock pages for the full models.
Not investment advice.